Plaintiffs Invokana Lawsuit Claims That Side Effects Included Ketoacidosis, a Potentially Life-Threatening Condition

April 24, 2016 – – TheProductLawyers.com comments on a lawsuit filed in the Southern District of Alabama between a plaintiff and Janssen Pharmaceuticals, maker of Invokana. The plaintiff claims that Invokana use caused her to develop ketoacidosis, a potentially life-threatening condition. She claims that the Type II Diabetes drug was prescribed to her in December 2014 and that she had been taking it for a very short time when she developed ketoacidosis, a condition which primarily affects diabetic individuals.

Ketoacidosis is a condition related to toxic acids in the blood. The condition tends to take effect very rapidly, often within less than 24 hours, and in this short amount of time coma or even death may occur. As a result of several adverse event reports received by the agency, the FDA has asked that any patient currently taking Invokana or any other SGLT2 inhibitors like it be on the lookout constantly for the side effects, which may present even without high blood sugar, a traditional precursor to the condition. These side effects are frequent urination, excessive thirst, vomiting and nausea and even shortness of breath or confusion.

This particular lawsuit alleges that not only was the drug related to the condition that the plaintiff found herself in, but also that the makers of the drug were negligent in not informing patients of the potential risk of developing it. She claims that the company must have been made aware of the prevalence of the condition in patients taking the drug during the clinical trial process and therefore should have passed the warning on to patients who were taking the drug. The FDA has released a notice to the company after receiving several adverse event reports related to the drug and ketoacidosis. The notice acknowledges the possibility of a link and requires the company to issue a new warning label with the drug which will better inform potential patients of the side effects that may present, including ketoacidosis.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009495